Your browser doesn't support javascript.
loading
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
Saner, Flurina A M; Takahashi, Kazuaki; Budden, Timothy; Pandey, Ahwan; Ariyaratne, Dinuka; Zwimpfer, Tibor A; Meagher, Nicola S; Fereday, Sian; Twomey, Laura; Pishas, Kathleen I; Hoang, Therese; Bolithon, Adelyn; Traficante, Nadia; Alsop, Kathryn; Christie, Elizabeth L; Kang, Eun-Young; Nelson, Gregg S; Ghatage, Prafull; Lee, Cheng-Han; Riggan, Marjorie J; Alsop, Jennifer; Beckmann, Matthias W; Boros, Jessica; Brand, Alison H; Brooks-Wilson, Angela; Carney, Michael E; Coulson, Penny; Courtney-Brooks, Madeleine; Cushing-Haugen, Kara L; Cybulski, Cezary; El-Bahrawy, Mona A; Elishaev, Esther; Erber, Ramona; Gayther, Simon A; Gentry-Maharaj, Aleksandra; Blake Gilks, C; Harnett, Paul R; Harris, Holly R; Hartmann, Arndt; Hein, Alexander; Hendley, Joy; Hernandez, Brenda Y; Jakubowska, Anna; Jimenez-Linan, Mercedes; Jones, Michael E; Kaufmann, Scott H; Kennedy, Catherine J; Kluz, Tomasz; Koziak, Jennifer M; Kristjansdottir, Björg.
Afiliação
  • Saner FAM; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Takahashi K; Department of Obstetrics and Gynecology, Bern University Hospital and University of Bern, Bern, Switzerland.
  • Budden T; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Pandey A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
  • Ariyaratne D; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.
  • Zwimpfer TA; Skin Cancer and Ageing Lab, Cancer Research United Kingdom Manchester Institute, The University of Manchester, Manchester, UK.
  • Meagher NS; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Fereday S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Twomey L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Pishas KI; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.
  • Hoang T; The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, New South Wales, Australia.
  • Bolithon A; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Traficante N; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Alsop K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Christie EL; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Kang EY; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Nelson GS; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Ghatage P; School of Clinical Medicine, UNSW Medicine and Health, University of NSW Sydney, Sydney, New South Wales, Australia.
  • Lee CH; Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
  • Riggan MJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Alsop J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Beckmann MW; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Boros J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Brand AH; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Brooks-Wilson A; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.
  • Carney ME; Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.
  • Coulson P; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Courtney-Brooks M; Department of Oncology, Division of Gynecologic Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Cushing-Haugen KL; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Cybulski C; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC, USA.
  • El-Bahrawy MA; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Elishaev E; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
  • Erber R; Centre for Cancer Research, The Westmead Institute for Medical Research, Sydney, New South Wales, Australia.
  • Gayther SA; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Gentry-Maharaj A; The University of Sydney, Sydney, New South Wales, Australia.
  • Blake Gilks C; Department of Gynaecological Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Harnett PR; The University of Sydney, Sydney, New South Wales, Australia.
  • Harris HR; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada.
  • Hartmann A; Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
  • Hein A; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Hendley J; Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Hernandez BY; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland.
  • Jakubowska A; Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Hospital, London, UK.
  • Jimenez-Linan M; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Jones ME; Institute of Pathology, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Erlangen, Germany.
  • Kaufmann SH; Center for Bioinformatics and Functional Genomics and the Cedars Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Kennedy CJ; MRC Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Kluz T; Department of Women's Cancer, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.
  • Koziak JM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Kristjansdottir B; The University of Sydney, Sydney, New South Wales, Australia.
medRxiv ; 2023 Nov 10.
Article em En | MEDLINE | ID: mdl-37986741
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos